Monforte Ad - Search Results

1

Insulin resistance affects early virologic response in HIV-infected subjects treated for hepatitis C infection.

Bongiovanni M, Ranieri R, Casana M, Tordato F, Cicconi P, Tincati C, Bini T, Monforte Ad. Bongiovanni M, et al. Among authors: monforte ad. J Acquir Immune Defic Syndr. 2008 Feb 1;47(2):258-9. doi: 10.1097/QAI.0b013e318158befd. J Acquir Immune Defic Syndr. 2008. PMID: 18223362 No abstract available.

2

Is the increased risk of liver enzyme elevation in patients co-infected with HIV and hepatitis virus greater in those taking antiretroviral therapy?

Cicconi P, Cozzi-Lepri A, Phillips A, Puoti M, Antonucci G, Manconi PE, Tositti G, Colangeli V, Lichtner M, Monforte Ad; ICoNA Study Group. Cicconi P, et al. Among authors: monforte ad. AIDS. 2007 Mar 12;21(5):599-606. doi: 10.1097/QAD.0b013e328013db9c. AIDS. 2007. PMID: 17314522

3

Is the CD4 cell percentage a better marker of immunosuppression than the absolute CD4 cell count in HIV-infected patients with cirrhosis?

Bongiovanni M, Gori A, Lepri AC, Antinori A, de Luca A, Pagano G, Chiodera A, Puoti M, Monforte Ad; Italian Cohort of Antiretroviral-Naive Patients Study Group. Bongiovanni M, et al. Among authors: monforte ad. Clin Infect Dis. 2007 Sep 1;45(5):650-3. doi: 10.1086/520025. Epub 2007 Aug 1. Clin Infect Dis. 2007. PMID: 17683003

4

Untangling the immunological implications of nadir on CD4+ cell recovery during suppressive highly active antiretroviral therapy.

Ferraris L, Bellistri GM, Pegorer V, Tincati C, Meroni L, Galli M, Monforte Ad, Gori A, Marchetti G. Ferraris L, et al. Among authors: monforte ad. Clin Infect Dis. 2008 Jan 1;46(1):149-50. doi: 10.1086/524087. Clin Infect Dis. 2008. PMID: 18171234 No abstract available.

5

The challenge of IL-2 immunotherapy in HIV disease: "no through road" or turning point?

Marchetti G, Tincati C, Monforte Ad, Gori A. Marchetti G, et al. Among authors: monforte ad. Curr HIV Res. 2008 May;6(3):189-99. doi: 10.2174/157016208784325029. Curr HIV Res. 2008. PMID: 18473782 Review.

6

Vertebral fractures in AIDS patients within 6 months from highly active antiretroviral therapy initiation: two case reports.

Gazzola L, Bini T, Pietrogrande L, Uziel L, Cicconi P, Casana M, Monforte Ad. Gazzola L, et al. Among authors: monforte ad. AIDS. 2008 May 31;22(9):1094-7. doi: 10.1097/QAD.0b013e3282ffdea6. AIDS. 2008. PMID: 18520358 No abstract available.

7

Serum alpha-fetoprotein levels predict early virologic response in HIV-positive subjects treated for chronic hepatitis C.

Bongiovanni M, Ranieri R, Tincati C, Casana M, Marchetti G, Monforte Ad. Bongiovanni M, et al. Among authors: monforte ad. J Acquir Immune Defic Syndr. 2008 Jul 1;48(3):361-3. doi: 10.1097/QAI.0b013e3181626fb8. J Acquir Immune Defic Syndr. 2008. PMID: 18580339 Free article. No abstract available.

8

Abacavir and cardiovascular risk in HIV-infected patients: does T lymphocyte hyperactivation exert a pathogenic role?

Marchetti G, Casana M, Tincati C, Bellistrì GM, Monforte Ad. Marchetti G, et al. Among authors: monforte ad. Clin Infect Dis. 2008 Dec 1;47(11):1495-6. doi: 10.1086/593110. Clin Infect Dis. 2008. PMID: 18986270 Free article. No abstract available.

9

The absence of CD4+ T cell count recovery despite receipt of virologically suppressive highly active antiretroviral therapy: clinical risk, immunological gaps, and therapeutic options.

Gazzola L, Tincati C, Bellistrì GM, Monforte Ad, Marchetti G. Gazzola L, et al. Among authors: monforte ad. Clin Infect Dis. 2009 Feb 1;48(3):328-37. doi: 10.1086/595851. Clin Infect Dis. 2009. PMID: 19123868 Review.

10

Calendar time trends in the incidence and prevalence of triple-class virologic failure in antiretroviral drug-experienced people with HIV in Europe.

Pursuing Later Treatment Options II (PLATO II) project team; Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Group; Nakagawa F, Lodwick R, Costagliola D, van Sighem A, Torti C, Podzamczer D, Mocroft A, Ledergerber B, Dorrucci M, Cozzi-Lepri A, Jansen K, Masquelier B, García F, De Wit S, Stephan C, Obel N, Fätkenhaeuer G, Castagna A, Sambatakou H, Mussini C, Ghosn J, Zangerle R, Duval X, Meyer L, Perez-Hoyos S, Fabre Colin C, Kjaer J, Chene G, Grarup J, Phillips A. Pursuing Later Treatment Options II (PLATO II) project team, et al. J Acquir Immune Defic Syndr. 2012 Mar 1;59(3):294-9. doi: 10.1097/QAI.0b013e31823fe66b. J Acquir Immune Defic Syndr. 2012. PMID: 22083070

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

261 results

Search Page